Daniel Bradshaw

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Venues

BMJ open

Journal of infection prevention

Journal of viral hepatitis

HIV medicine

Public Health England

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Public Health England

United Kingdom

Consultant Medical Virologist

Publications

Daniel Bradshaw, Kathryn Harrison, Emma Page, Yusri Taha, Marian Killip, Sharon Parkes, Carla Lloyd, Maria Kokocinska, Katherine Davies, Tracy Beetar-King, Maria Zambon, Deirdre Kelly
A surveillance study of SARS-CoV-2 infection in immunosuppressed patients. Journal of infection prevention 25 (1-2) (2024)
Daniel Bradshaw, Kathryn Harrison, Emma Page, Yusri Taha, Marian Killip, Sharon Parkes, Carla Lloyd, Maria Kokocinska, Katherine Davies, Tracy Beetar-King, Maria Zambon, Deirdre Kelly
A surveillance study of SARS-CoV-2 infection in immunosuppressed patients. Journal of infection prevention 25 (1-2) (2024)
Maxime Desmarets, Simone Hoffmann, Charline Vauchy, Bart J A Rijnders, Eric Toussirot, Antoine Durrbach, Sixten Körper, Eva Schrezenmeier, C Ellen van der Schoot, Heli Harvala, Gaëlle Brunotte, Thomas Appl, Erhard Seifried, Pierre Tiberghien, Daniel Bradshaw, David J Roberts, Lise J Estcourt, Hubert Schrezenmeier
Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19 (COVIC-19): protocol for a randomised, open-label trial. BMJ open 13 (4) (2023)
Maxime Desmarets, Simone Hoffmann, Charline Vauchy, Bart J A Rijnders, Eric Toussirot, Antoine Durrbach, Sixten Körper, Eva Schrezenmeier, C Ellen van der Schoot, Heli Harvala, Gaëlle Brunotte, Thomas Appl, Erhard Seifried, Pierre Tiberghien, Daniel Bradshaw, David J Roberts, Lise J Estcourt, Hubert Schrezenmeier
Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19 (COVIC-19): protocol for a randomised, open-label trial. BMJ open 13 (4) (2023)
Maxime Desmarets, Simone Hoffmann, Charline Vauchy, Bart J A Rijnders, Eric Toussirot, Antoine Durrbach, Sixten Körper, Eva Schrezenmeier, C Ellen van der Schoot, Heli Harvala, Gaëlle Brunotte, Thomas Appl, Erhard Seifried, Pierre Tiberghien, Daniel Bradshaw, David J Roberts, Lise J Estcourt, Hubert Schrezenmeier
Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19 (COVIC-19): protocol for a randomised, open-label trial. BMJ open 13 (4) (2023)
Maxime Desmarets, Simone Hoffmann, Charline Vauchy, Bart J A Rijnders, Eric Toussirot, Antoine Durrbach, Sixten Körper, Eva Schrezenmeier, C Ellen van der Schoot, Heli Harvala, Gaëlle Brunotte, Thomas Appl, Erhard Seifried, Pierre Tiberghien, Daniel Bradshaw, David J Roberts, Lise J Estcourt, Hubert Schrezenmeier
Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19 (COVIC-19): protocol for a randomised, open-label trial. BMJ open 13 (4) (2023)
Daniel Bradshaw, Iga Abramowicz, Stephen Bremner, Sumita Verma, Yvonne Gilleece, Sarah Kirk, Mark Nelson, Rosalie Housman, Helena Miras, Chloe Orkin, Ashini Fox, Michael Curnock, Louise Jennings, Mark Gompels, Emily Clarke, Rachel Robinson, Pauline Lambert, David Chadwick, Nicky Perry
Hepmarc: A 96 week randomised controlled feasibility trial of add-on maraviroc in people with HIV and non-alcoholic fatty liver disease. PloS one 18 (7) (2023)
Maxime Desmarets, Simone Hoffmann, Charline Vauchy, Bart J A Rijnders, Eric Toussirot, Antoine Durrbach, Sixten Körper, Eva Schrezenmeier, C Ellen van der Schoot, Heli Harvala, Gaëlle Brunotte, Thomas Appl, Erhard Seifried, Pierre Tiberghien, Daniel Bradshaw, David J Roberts, Lise J Estcourt, Hubert Schrezenmeier
Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19 (COVIC-19): protocol for a randomised, open-label trial. BMJ open 13 (4) (2023)
Alison E Brown, Sara E Croxford, Sophie Grace Nash, Jameel Khawam, Peter D Kirwan, Meaghan Kall, Daniel Bradshaw, Caroline Anne Sabin, Robert F Miller, Frank A Post, Richard Harding, Simon Collins, Laura Jane Waters, David Asboe, David R Chadwick, Valerie C Delpech, Ann K Sullivan
COVID-19 mortality among people with diagnosed HIV compared to those without during the first wave of the COVID-19 pandemic in England. HIV medicine (2021)
David A Smith, Daniel Bradshaw, Jean L Mbisa, Carmen F Manso, David F Bibby, Joshua B Singer, Emma C Thomson, Ana da Silva Filipe, Elihu Aranday-Cortes, M Azim Ansari, Anthony Brown, Emma Hudson, Jennifer Benselin, Brendan Healy, Phil Troke, John McLauchlan, Eleanor Barnes, William Lucien Irving
Real world SOF/VEL/VOX retreatment outcomes and viral resistance analysis for HCV patients with prior failure to DAA therapy. Journal of viral hepatitis 28 (9) (2021)
Daniel Bradshaw, Tetyana I Vasylyeva, Chris Davis, Oliver G Pybus, Julien Thézé, Emma C Thomson, Marianne Martinello, Gail V Matthews, Ruth Burholt, Yvonne Gilleece, Graham S Cooke, Emma E Page, Laura Waters, Mark Nelson
Transmission of hepatitis C virus in HIV-positive and PrEP-using MSM in England. Journal of viral hepatitis 27 (7) (2020)
Daniel Bradshaw, Yvonne Gilleece, Sumita Verma, Iga Abramowicz, Stephen Bremner, Nicky Perry
Protocol for a phase IV, open-label feasibility study investigating non-invasive markers of hepatic fibrosis in people living with HIV-1 and non-alcoholic fatty liver disease randomised to receiving optimised background therapy (OBT) plus maraviroc or OBT alone. BMJ open 10 (7) (2020)

Daniel Bradshaw.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Daniel Bradshaw